Linda R. Mileshkin, MBBS, FRACP, Mbioeth, highlights efficacy data with puxitatug samrotecan in patients with ovarian and endometrial cancers.
Linda R. Mileshkin, MBBS, FRACP, Mbioeth
Advertisement
Linda R. Mileshkin, MBBS, FRACP, Mbioeth, is director of Medical Oncology at Peter MacCallum Cancer Centre.
Articles by Linda R. Mileshkin, MBBS, FRACP, Mbioeth
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Fast Track Designation to Pelareorep in Pretreated SCAC
2
CD33-Directed CAR T-Cell Therapies Elicit Complete Remissions in Relapsed/Refractory AML
3
Subcutaneous Pembrolizumab Faces Scrutiny Over Convenience and Cost for Patients With Cancer
4
The OncFive: Top Oncology Articles for the Week of 7/12
5